tailieunhanh - Ebook Drug and device selection in heart failure: Part 2

(BQ) Part 2 book "Drug and device selection in heart failure" presents the following contents: Percutaneous mechanical support, cardiac resynchronization therapy, atrial arrhythmias in heart failure, heart transplantation, heart failure, ventricular tachyarrhythmias in patients with congestive heart failure,. | CHAPTER Percutaneous Mechanical Support 8 Raphael E Bonita Kariann Abbate INTRODUCTION There are approximately million people in the United States living with heart failure HF .1 These numbers are expected to increase over the next decade due to the aging population. Despite the increasing prevalence of HF the number of donor hearts available for transplant has remained stagnant. In 2010 there were 2 333 heart transplants performed in the United A severe donor shortage has limited the availability of donor hearts resulting in prolonged waits for organs for patients with advanced HF. Furthermore more than 200 000 patients with heart failure are not eligible for transplant due to age or The advent of mechanical circulatory support has decreased mortality and improved the quality of life for patients awaiting heart transplantation as well as for those ineligible for transplantation. INDICATIONS FOR MECHANICAL ASSIST DEVICES Mechanical assist devices are indicated for patients who are failing optimal medical therapy. When patients are exhibiting evidence of end-organ dysfunction despite optimal medical therapy mechanical assist devices should be considered. Mechanical assist devices are used for both acute and chronic HF. The National Institute of Health has developed profiles using data from Interagency Registry for Mechanically Assisted Circulatory Support INTERMACS to assist in clarification of target populations for mechanical assist devices Table 1 . There are three main indications for mechanical assist devices 1 bridge to myocardial recovery 2 bridge to cardiac transplantation and 3 destination therapy. Bridge to Recovery Mechanical assist devices are commonly used to support patients suffering from postcardiotomy shock that are unable to be weaned from cardiopulmonary bypass Chapter 8 Percutaneous Mechanical Support 111 1 INTERMACS profile description Clinical presentations Time frame for intervention Profile 1 Critical cardiogenic

• Y khoa - Dược
• Drug in heart failure
• Device selection in heart failure
• Percutaneous mechanical support
• Cardiac resynchronization therapy
• Atrial arrhythmias in heart failure
• Heart transplantation
• Heart failure
• The pathophysiology of heart failure
• Traditional mechanical support
• Inotropic therapy for heart failure
• BMC Pediatrics
• Chronic heart failure
• Coronary artery disease
• Drug application
• Older patients
• Mortality rate
• BMC Pharmacology and Toxicology
• Drug delivery
• High blood pressure
• Physical inactivity
• Acute stress
• Heart disease
• BMC Molecular and Cell Biology
• Prostaglandin E2
• Prostaglandin E2 receptor subtype 4
• Homology model
• Structure based drug design
• Bone healing
• Lecture heart failure
• Classification of heart failure
• The cause of heart failure
• Symptoms of heart failure
• Heart failure Definition
• Patients with chronic heart failure
• Self care among patients
• Patient’s knowledge about heart failure
• Physical activity of the patients
• BMC Genomics
• RNA seq
• Gene expression
• Current heart failure
• Etiology specific gene
• BMC Geriatrics
• Heart failure stages
• Population attributable risk
• All cause mortality
• Heart failure management
• The neural pathways
• Barorefl ex activation therapy in heart failure
• Modulation of autonomic function
• Therapies in heart failure
• Listening to the heart
• Nervous system regulation
• Cerebral aging
• The autonomic nervous system
• NT proBNP
• Premature ventricular complexes
• Stable ischemic heart disease
• Chronic ischemic heart disease
• Heart muscle disease
• Heart rhythm disorders
• Peripheral vascular disease
• Heart disease in the young
• Heart disease in the elderly
• Cardiovascular drugs
• Evaluation and management
• Right sided heart failure
• Right heart failure
• Main points of RHF
• Cardiac embryogenesis
• BMC Veterinary Research
• Platelet proteomic
• Myxomatous mitral valve disease
• Congestive heart failure
• knowledge of medicine
• pharmacy management
• medication management
• vasodilators
• Extracorporeal membrane oxygenation
• Pathophysiology of heart failure
• Pediatric patients
• Respiratory failure
• Diastolic heart failure
• Cardiogenic shock
• Cardiovascular diseases
• Ischemic Heart Disease
• Stable ischemic heart disease
• Acute coronary syndromes
• Cardiac arrhythmias
• Ischemic stroke
• MCQs for cardiology knowledge based assessment
• Cardiology knowledge based assessment
• Ischaemic heart disease
• Valvular heart disease
• Adult congenital heart disease
• Pathophysiology of heart diseas
• The cardiomyopathies
• Mechanisms of cardiac arrhythmias
• Clinical aspects of cardiac arrhythmias
• Congenital heart disease
• Diseases of the pericardium
• Cardiology clinical questions
• Cardiology clinical
• Congenital heart diseases
• Heart failure and hypertension
• Managing chronic heart failure patient
• Chronic kidney disease
• Modification of risk factors
• Quản lý bệnh nhân suy tim mãn tính
• Bệnh thận mãn tính
• Điều trị bệnh thận
• Study of clinical characteristic
• Risk factors
• Deep vein thrombosis
• Lower extremities
• Pulmonary emboli
• Practical cardiovascular medicine
• Non‐ST‐Segment elevation acute coronary syndrome
• ST‐segment elevation myocardial infarction
• Additional heart failure topics
• Valvular disorders
• Left ventricular filling pressure
• Diastolic dysfunction
• Echocardiography guidelines
• Doppler echocardiography
• Renal dysfunction
• Estimated glomerular filtration rate
• Left ventricular ejection fraction
• Serum BNP
• Heart failure with preserved ejection fraction
• Narrow QRS complex
• Speckle tracking echocardiography
• Dyssynchrony remains unclear
• QRS complex